Yüklüyor......
MiR-221/222 promote chemoresistance to cisplatin in ovarian cancer cells by targeting PTEN/PI3K/AKT signaling pathway
Cisplatin resistance is one of the main limitations in the treatment of ovarian cancer, and its mechanism has not been fully understood. The objectives of this study were to determine the role of miR-221/222 and its underlying mechanism in chemoresistance of ovarian cancer. We demonstrated that miR-...
Kaydedildi:
| Yayımlandı: | Cytotechnology |
|---|---|
| Asıl Yazarlar: | , , , |
| Materyal Türü: | Artigo |
| Dil: | Inglês |
| Baskı/Yayın Bilgisi: |
Springer Netherlands
2017
|
| Konular: | |
| Online Erişim: | https://ncbi.nlm.nih.gov/pmc/articles/PMC5809651/ https://ncbi.nlm.nih.gov/pubmed/28887606 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1007/s10616-017-0134-z |
| Etiketler: |
Etiketle
Etiket eklenmemiş, İlk siz ekleyin!
|